• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Case Study: DFU – Toe Wound


Patient History

  • Wound is approx. 1 year old
  • Diabetes
  • Paraplegia
  • Multiple Comorbidities (HTN, COPD, CAD, CHF)
  • Multiple reoccurring wounds

Treatment

Previous Treatments:

  • Other Biologic Skin Subs
  • Collagen, SOC treatment
  • NWPT

Outcome:

  • Mirragen applied and wound closed after 3 applications. Wound closed in less than 30 days.
12-23-2024 Before the 1st application of Mirragen
12-30-2024 After 1st application of Mirragen
01-06-2025 3rd Mirragen Application
1-20-2025

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care